Heiner Wedemeyer

51.2k total citations · 13 hit papers
840 papers, 29.2k citations indexed

About

Heiner Wedemeyer is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Heiner Wedemeyer has authored 840 papers receiving a total of 29.2k indexed citations (citations by other indexed papers that have themselves been cited), including 721 papers in Hepatology, 598 papers in Epidemiology and 91 papers in Immunology. Recurrent topics in Heiner Wedemeyer's work include Hepatitis C virus research (562 papers), Hepatitis B Virus Studies (418 papers) and Liver Disease Diagnosis and Treatment (382 papers). Heiner Wedemeyer is often cited by papers focused on Hepatitis C virus research (562 papers), Hepatitis B Virus Studies (418 papers) and Liver Disease Diagnosis and Treatment (382 papers). Heiner Wedemeyer collaborates with scholars based in Germany, United States and France. Heiner Wedemeyer's co-authors include Michael P. Manns, Markus Cornberg, Stefan Zeuzem, Francesco Negro, Katja Deterding, Marina Berenguer, Jean–Michel Pawlotsky, Sven Pischke, Geoffrey Dusheiko and Massimo Puoti and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Heiner Wedemeyer

779 papers receiving 28.5k citations

Hit Papers

EASL Recommendations on Tr... 2001 2026 2009 2017 2018 2012 2020 2014 2002 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. EASL Recommendations on Treatment of Hepatitis C 2018
    2018 1.5k citations Heiner Wedemeyer et al. Journal of Hepatology profile →
  2. Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
    2012 1.1k citations Heiner Wedemeyer, Michael P. Manns et al. profile →
  3. EASL recommendations on treatment of hepatitis C: Final update of the series☆
    2020 707 citations Heiner Wedemeyer et al. Journal of Hepatology profile →
  4. ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
    2014 646 citations Heiner Wedemeyer et al. profile →
  5. Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection
    2002 535 citations Heiner Wedemeyer et al. profile →
  6. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor #
    2009 529 citations Heiner Wedemeyer, Michael P. Manns et al. Hepatology profile →
  7. Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma
    2005 527 citations Heiner Wedemeyer, Michael P. Manns et al. profile →
  8. Treatment of Acute Hepatitis C with Interferon Alfa-2b
    2001 516 citations Markus Cornberg, Heiner Wedemeyer et al. profile →
  9. EASL Clinical Practice Guidelines on hepatitis E virus infection
    2018 415 citations Heiner Wedemeyer et al. Journal of Hepatology profile →
  10. Hepatitis E virus infection
    2017 396 citations Heiner Wedemeyer et al. profile →
  11. Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
    2014 395 citations Heiner Wedemeyer et al. profile →
  12. Prothrombotic immune thrombocytopenia after COVID-19 vaccination
    2021 119 citations Benjamin Maasoumy, Heiner Wedemeyer et al. profile →
  13. EASL Clinical Practice Guidelines on hepatitis delta virus
    2023 112 citations Heiner Wedemeyer, Marı́a Buti et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heiner Wedemeyer Germany 82 23.1k 19.8k 4.5k 3.9k 1.8k 840 29.2k
Thomas Berg Germany 73 20.3k 0.9× 20.4k 1.0× 3.2k 0.7× 2.1k 0.5× 2.1k 1.2× 726 28.1k
David L. Thomas United States 72 21.7k 0.9× 21.0k 1.1× 4.2k 0.9× 2.6k 0.7× 1.2k 0.7× 292 27.3k
Jean–Michel Pawlotsky France 82 19.7k 0.9× 17.6k 0.9× 3.5k 0.8× 1.5k 0.4× 2.4k 1.4× 467 24.6k
Raymond T. Chung United States 79 13.5k 0.6× 12.9k 0.7× 2.6k 0.6× 3.1k 0.8× 3.7k 2.1× 431 23.1k
Masashi Mizokami Japan 73 16.3k 0.7× 16.1k 0.8× 2.2k 0.5× 1.4k 0.4× 2.6k 1.5× 489 21.8k
John G. McHutchison United States 95 37.2k 1.6× 33.6k 1.7× 4.7k 1.0× 3.0k 0.8× 2.6k 1.5× 467 43.6k
Patrick Marcellin France 99 34.2k 1.5× 34.3k 1.7× 4.1k 0.9× 1.3k 0.3× 1.4k 0.8× 635 38.8k
Harry L.A. Janssen Netherlands 82 20.9k 0.9× 21.4k 1.1× 1.9k 0.4× 3.3k 0.9× 2.9k 1.6× 430 29.0k
Stanislas Pol France 71 15.1k 0.7× 14.2k 0.7× 3.1k 0.7× 1.1k 0.3× 925 0.5× 484 18.9k
Jules L. Dienstag United States 82 21.6k 0.9× 21.0k 1.1× 3.6k 0.8× 1.4k 0.4× 1.5k 0.8× 268 27.2k

Countries citing papers authored by Heiner Wedemeyer

Since Specialization
Citations

This map shows the geographic impact of Heiner Wedemeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heiner Wedemeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heiner Wedemeyer more than expected).

Fields of papers citing papers by Heiner Wedemeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heiner Wedemeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heiner Wedemeyer. The network helps show where Heiner Wedemeyer may publish in the future.

Co-authorship network of co-authors of Heiner Wedemeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Heiner Wedemeyer. A scholar is included among the top collaborators of Heiner Wedemeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heiner Wedemeyer. Heiner Wedemeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sandmann, Lisa, Birgit Bremer, Anke Kraft, et al.. (2025). Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection. Liver International. 45(2). e70003–e70003. 1 indexed citations
2.
Mundt, Bettina, Norman Woller, Valery Volk, et al.. (2025). Oncolytic viruses expressing MATEs facilitate target-independent T-cell activation in tumors. EMBO Molecular Medicine. 17(2). 265–300.
3.
Bremer, Birgit, Jörn Beheim-Schwarzbach, A. Kummrow, et al.. (2025). Droplet Digital PCR: A Powerful Tool for Accurate Quantification of Hepatitis D Virus RNA Levels and Verification of Detection Limits. Journal of Viral Hepatitis. 32(6). e70036–e70036.
4.
Petroff, David, Jörn M. Schattenberg, S Zeuzem, et al.. (2025). Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-Registry. Zeitschrift für Gastroenterologie. 63(8). 836–843. 1 indexed citations
5.
Richter, Nicolas, Bernhard Meyer, Benjamin Heidrich, et al.. (2025). Comparison of clinical outcomes in patients with refractory ascites treated with either TIPS, tunneled peritoneal catheter, or ascites pump. Hepatology Communications. 9(2). 2 indexed citations
6.
Liu, Zhaoli, Birgit Bremer, Jennifer Witt, et al.. (2024). Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis. Clinical and Molecular Hepatology. 31(1). 240–255. 3 indexed citations
7.
Gupta, Manoj Kumar, Birgit Bremer, Katja Deterding, et al.. (2024). Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition. Hepatology. 82(3). 739–754. 1 indexed citations
8.
Lampertico, Pietro, et al.. (2024). Antiviral therapy for chronic hepatitis delta: new insights from clinical trials and real-life studies. Gut. 74(5). 853–862. 7 indexed citations
9.
Allweiss, Lena, Vithika Suri, Jeffrey J. Wallin, et al.. (2024). Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies. Journal of Hepatology. 80(6). 882–891. 18 indexed citations
10.
Brüggemann, Yannick, et al.. (2024). Hepatitis E virus: from innate sensing to adaptive immune responses. Nature Reviews Gastroenterology & Hepatology. 21(10). 710–725. 5 indexed citations
11.
Hirmas, Nader, Catherine Leyh, Miriam Sraieb, et al.. (2021). 68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma. Journal of Nuclear Medicine. 62(9). 1235–1241. 52 indexed citations
12.
Stahl, Klaus, Yulia Kiyan, Benjamin Seeliger, et al.. (2021). Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shock. Intensive Care Medicine Experimental. 9(1). 57–57. 22 indexed citations
13.
Neubert, Lavinia, Kai Timrott, Huizhen Suo, et al.. (2021). Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancer. OncoImmunology. 10(1). 1874159–1874159. 14 indexed citations
14.
Deterding, Katja, Michael P. Manns, & Heiner Wedemeyer. (2018). Aktuelle Arzneimitteltherapie der Hepatitis C. Der Internist. 59(4). 401–409.
15.
Nguyen, Hung Minh, Bùi Tiến Sỹ, Nguyễn Thành Trung, et al.. (2017). Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam. PLoS ONE. 12(4). e0175304–e0175304. 18 indexed citations
16.
Niro, Grazia Anna, Antonina Smedile, Rosanna Fontana, et al.. (2016). HBsAg kinetics in chronic hepatitis D during interferon therapy: on‐treatment prediction of response. Alimentary Pharmacology & Therapeutics. 44(6). 620–628. 40 indexed citations
17.
Deterding, Katja, Christoph Höner zu Siederdissen, Kerstin Port, et al.. (2015). Improvement of liver function parameters in advanced HCV ‐associated liver cirrhosis by IFN ‐free antiviral therapies. Alimentary Pharmacology & Therapeutics. 42(7). 889–901. 87 indexed citations
18.
Suneetha, Pothakamuri Venkata, Sven Pischke, Verena Schlaphoff, et al.. (2011). Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology. 55(3). 695–708. 131 indexed citations
19.
Reijnders, Jurriën G.P., Katja Deterding, Jörg Petersen, et al.. (2010). Antiviral effect of entecavir in chronic hepatitis B: Influence of prior exposure to nucleos(t)ide analogues. Journal of Hepatology. 52(4). 493–500. 85 indexed citations
20.
Manns, Michael P., Johannes Hadem, & Heiner Wedemeyer. (2004). Hepatitis B Virus: Where Are We and Where Are We Going?. Humana Press eBooks. 96. 415–444. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Berg Breakdown of academic impact, for papers by David L. Thomas Breakdown of academic impact, for papers by Jean–Michel Pawlotsky Breakdown of academic impact, for papers by Raymond T. Chung Breakdown of academic impact, for papers by Masashi Mizokami Breakdown of academic impact, for papers by John G. McHutchison Breakdown of academic impact, for papers by Patrick Marcellin Breakdown of academic impact, for papers by Harry L.A. Janssen Breakdown of academic impact, for papers by Stanislas Pol Breakdown of academic impact, for papers by Jules L. Dienstag
Rankless by CCL
2026